These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32405727)

  • 1. Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1.
    Courtney E; Chan SH; Li ST; Ishak D; Merchant K; Shaw T; Chay WY; Chin FHX; Wong WL; Wong A; Ngeow J
    Fam Cancer; 2020 Oct; 19(4):353-358. PubMed ID: 32405727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
    Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1.
    Norris EJ; Jones WD; Surleac MD; Petrescu AJ; Destephanis D; Zhang Q; Hamadeh I; Kneisl JS; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
    Gynecol Oncol Rep; 2018 Feb; 23():41-44. PubMed ID: 29892687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer.
    Güran S; Safali M
    Cancer Genet Cytogenet; 2005 Jan; 156(1):86-8. PubMed ID: 15588864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset malignant phyllodes breast tumor in a patient with germline pathogenic variants in NF1 and BRCA1 genes.
    Gensini F; Sestini R; De Luca A; Pinna V; Daniele P; Orzalesi L; Petrella MC; Porfirio B; Papi L
    Fam Cancer; 2021 Jul; 20(3):195-199. PubMed ID: 33210232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.
    Bausch B; Borozdin W; Mautner VF; Hoffmann MM; Boehm D; Robledo M; Cascon A; Harenberg T; Schiavi F; Pawlu C; Peczkowska M; Letizia C; Calvieri S; Arnaldi G; Klingenberg-Noftz RD; Reisch N; Fassina A; Brunaud L; Walter MA; Mannelli M; MacGregor G; Palazzo FF; Barontini M; Walz MK; Kremens B; Brabant G; Pfäffle R; Koschker AC; Lohoefner F; Mohaupt M; Gimm O; Jarzab B; McWhinney SR; Opocher G; Januszewicz A; Kohlhase J; Eng C; Neumann HP;
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2784-92. PubMed ID: 17426081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital Retroperitoneal Teratoma in Neurofibromatosis Type 1.
    Yap P; Super L; Qin J; Burgess T; Prodanovic Z; Edwards C; Thomas R; Carpenter K; Tan TY
    Pediatr Blood Cancer; 2016 Apr; 63(4):706-8. PubMed ID: 26514327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital disseminated neurofibromatosis type 1: a clinical and molecular case report.
    Stewart H; Bowker C; Edees S; Smalley S; Crocker M; Mechan D; Forrester N; Spurlock G; Upadhyaya M
    Am J Med Genet A; 2008 Jun; 146A(11):1444-52. PubMed ID: 18438896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The R1947X mutation of NF1 causing autosomal dominant neurofibromatosis type 1 in a Chinese family.
    Yang Q; Huang C; Yang X; Feng Y; Wang Q; Liu M
    J Genet Genomics; 2008 Feb; 35(2):73-6. PubMed ID: 18407053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
    Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
    J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NF1 somatic mutational landscape in sporadic human cancers.
    Hum Genomics; ; . PubMed ID: 28637487
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.